List of Tables
Table 1. Global HIV & AIDS Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Kits and Reagents
Table 3. Key Players of Instruments
Table 4. Key Players of Others
Table 5. Global HIV & AIDS Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global HIV & AIDS Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global HIV & AIDS Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global HIV & AIDS Diagnostics Market Share by Region (2020-2025)
Table 9. Global HIV & AIDS Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global HIV & AIDS Diagnostics Market Share by Region (2026-2031)
Table 11. HIV & AIDS Diagnostics Market Trends
Table 12. HIV & AIDS Diagnostics Market Drivers
Table 13. HIV & AIDS Diagnostics Market Challenges
Table 14. HIV & AIDS Diagnostics Market Restraints
Table 15. Global HIV & AIDS Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global HIV & AIDS Diagnostics Market Share by Players (2020-2025)
Table 17. Global Top HIV & AIDS Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV & AIDS Diagnostics as of 2024)
Table 18. Ranking of Global Top HIV & AIDS Diagnostics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by HIV & AIDS Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of HIV & AIDS Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of HIV & AIDS Diagnostics, Product and Application
Table 22. Global Key Players of HIV & AIDS Diagnostics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV & AIDS Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global HIV & AIDS Diagnostics Revenue Market Share by Type (2020-2025)
Table 26. Global HIV & AIDS Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global HIV & AIDS Diagnostics Revenue Market Share by Type (2026-2031)
Table 28. Global HIV & AIDS Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global HIV & AIDS Diagnostics Revenue Market Share by Application (2020-2025)
Table 30. Global HIV & AIDS Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global HIV & AIDS Diagnostics Revenue Market Share by Application (2026-2031)
Table 32. North America HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific HIV & AIDS Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific HIV & AIDS Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa HIV & AIDS Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa HIV & AIDS Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Siemens Healthineers Company Details
Table 48. Siemens Healthineers Business Overview
Table 49. Siemens Healthineers HIV & AIDS Diagnostics Product
Table 50. Siemens Healthineers Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 51. Siemens Healthineers Recent Development
Table 52. Bio-Rad Company Details
Table 53. Bio-Rad Business Overview
Table 54. Bio-Rad HIV & AIDS Diagnostics Product
Table 55. Bio-Rad Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 56. Bio-Rad Recent Development
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories HIV & AIDS Diagnostics Product
Table 60. Abbott Laboratories Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. OraSure Technologies Company Details
Table 63. OraSure Technologies Business Overview
Table 64. OraSure Technologies HIV & AIDS Diagnostics Product
Table 65. OraSure Technologies Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 66. OraSure Technologies Recent Development
Table 67. F. Hoffmann-La Roche Company Details
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche HIV & AIDS Diagnostics Product
Table 70. F. Hoffmann-La Roche Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Hologic Company Details
Table 73. Hologic Business Overview
Table 74. Hologic HIV & AIDS Diagnostics Product
Table 75. Hologic Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 76. Hologic Recent Development
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott HIV & AIDS Diagnostics Product
Table 80. Abbott Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. Chembio Diagnostic Systems Company Details
Table 83. Chembio Diagnostic Systems Business Overview
Table 84. Chembio Diagnostic Systems HIV & AIDS Diagnostics Product
Table 85. Chembio Diagnostic Systems Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 86. Chembio Diagnostic Systems Recent Development
Table 87. Becton, Dickinson and Company Company Details
Table 88. Becton, Dickinson and Company Business Overview
Table 89. Becton, Dickinson and Company HIV & AIDS Diagnostics Product
Table 90. Becton, Dickinson and Company Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 91. Becton, Dickinson and Company Recent Development
Table 92. Danaher Corporation(Cepheid) Company Details
Table 93. Danaher Corporation(Cepheid) Business Overview
Table 94. Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Product
Table 95. Danaher Corporation(Cepheid) Revenue in HIV & AIDS Diagnostics Business (2020-2025) & (US$ Million)
Table 96. Danaher Corporation(Cepheid) Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. HIV & AIDS Diagnostics Picture
Figure 2. Global HIV & AIDS Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HIV & AIDS Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Kits and Reagents Features
Figure 5. Instruments Features
Figure 6. Others Features
Figure 7. Global HIV & AIDS Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global HIV & AIDS Diagnostics Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Private Diagnostic Laboratories Case Studies
Figure 11. Academic and Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. HIV & AIDS Diagnostics Report Years Considered
Figure 14. Global HIV & AIDS Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global HIV & AIDS Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global HIV & AIDS Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global HIV & AIDS Diagnostics Market Share by Players in 2024
Figure 18. Global Top HIV & AIDS Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV & AIDS Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by HIV & AIDS Diagnostics Revenue in 2024
Figure 20. North America HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America HIV & AIDS Diagnostics Market Share by Country (2020-2031)
Figure 22. United States HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe HIV & AIDS Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific HIV & AIDS Diagnostics Market Share by Region (2020-2031)
Figure 34. China HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America HIV & AIDS Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa HIV & AIDS Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE HIV & AIDS Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Siemens Healthineers Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 50. Bio-Rad Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 52. OraSure Technologies Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 54. Hologic Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 55. Abbott Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 56. Chembio Diagnostic Systems Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 57. Becton, Dickinson and Company Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 58. Danaher Corporation(Cepheid) Revenue Growth Rate in HIV & AIDS Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed